FindTrial
Sign In

Establishment and empirical study of catheter intervention scheme after prostatic hyperplasia based on ACE Star model

Establishment and empirical study of catheter intervention scheme after prostatic hyperplasia based on ACE Star model

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300069364
Enrollment
Unknown
Registered
2023-03-14
Start date
2023-03-15
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Benign Prostatic Hyperplasia

Interventions

Intervention group:Based on the evidence obtained after prostatic hyperplasia postoperative catheter intervention program
control group:Routine nursing measures

Sponsors

Shaoxing People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Hospitalized patients with hyperplasia of prostate; 2. Patients undergoing surgery for prostatic hyperplasia for the first time; 3. Clear consciousness, with normal language communication ability; 4. Informed consent, willing to participate in the study.

Exclusion criteria

Exclusion criteria: 1. Patients with prostatic hyperplasia undergoing open surgery; 2. Patients with congenital urethral stricture; 3. Patients with malignant tumors accompanied by cancer pain; 4. Patients with long-term use of analgesics; 5. Suffering from mental illness or cognitive impairment.

Design outcomes

Primary

MeasureTime frame
Comfort of indwelling catheterization;Pain level during extubation;Indwelling catheterization recatheterization rate;CAUTI incidence;—

Countries

China

Contacts

Public ContactHuali Xu

Shaoxing People's Hospital

450604478@qq.com+86 575 8855 9253

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026